Fashion has a message for you. It is written in cut-outs and sheer panels and dresses engineered to pull taut across a torso. If you grew up in the nineties, the message feels familiar.
For a beautiful, chaotic decade, the industry genuinely seemed to be making space. Runways got a little wider, brands stocked sizes beyond S-L. Body positivity, neutrality and midsize creators built communities out of the radical act of existing at a size beyond 10 and dressing well. Progress, fitful and incomplete, but pointing somewhere new. The cultural moment that produced all of that was also running out of road, and GLP-1s like Ozempic, Mounjaro and Wegovy arrived at an interesting time.
The algorithm noticed before most of us did. One search, one article, and within days the advertisements followed: telehealth, semaglutide, before and afters. Red carpet appearances and celebrity transformations did the rest. Somewhere between the prescription pad for medical conditions and the paparazzi shot, GLP-1s became something else; thinness shifted from aspirational to ‘easily’ attainable. Fashion, as it always does, paid close attention.
According to the Wall Street Journal, retailers began reporting customers replacing entire wardrobes at once, jumping multiple sizes in a single season, which executives said they had no precedent for. One brand introduced a size 000. The runway followed with recent collections across Paris, Milan and New York, converging on exposed midriffs, corseted waists and naked dresses. Per Vogue Business, the share of runway shows featuring a plus-size model dropped from 11.5% to 4.6% in two seasons.
The body the clothes are designed for is, increasingly, a very specific one. And the designs make no secret of it. A dress built around a torso cut-out doesn’t reveal the body; it requires a particular body type. Remove the specific body it assumes and the whole thing falls apart.
But the Ozempic era didn’t invent fashion’s preference for a narrow silhouette. That preference is old and stubborn and has survived every cultural correction aimed at it, including the body positivity movement, which, at its peak, briefly made the industry blink. What the Ozempic era did was make that preference clearly visible once again. And visibility, as the last decade proved, is where change begins.
The millennial women standing in changing rooms right now—going looking for a cap sleeve and coming home empty-handed—have been here before. We lived through the first version of this story, written in low-rise jeans, diet culture and the tyranny of the bandage dress. We’re also the same women who drove the body positivity movement in the first place. Not always from the outside, throwing stones, but from inside the industry: the editors, stylists, creators, customers whose spending made inclusive sizing commercially viable. They got loud about it, spent their money differently, demanded more, and the industry—slowly, grudgingly, genuinely—moved. Not because fashion had a change of heart. Because the woman in the changing room did, and she took her debit card with her.
Disclaimer : This story is auto aggregated by a computer programme and has not been created or edited by DOWNTHENEWS. Publisher: vogue.in
